Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
Open Access
- 3 April 2017
- journal article
- review article
- Published by Taylor & Francis Ltd in Human Vaccines & Immunotherapeutics
- Vol. 13 (6), 1288-1296
- https://doi.org/10.1080/21645515.2017.1290018
Abstract
A universal vaccine that provides long-lasting protection from both epidemic and pandemic influenza viruses remains the “holy grail” of influenza vaccine research. Though virus neutralization assays are the current benchmark of measuring vaccine effectiveness, it is clear that Fc-receptor functions can drastically improve the effectiveness of antibodies and vaccines in vivo. Antibodies that kill virus-infected cells and/or elicit an antiviral environment, termed antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies, provide a link between the innate and adaptive immune response. New technologies allowing the rapid isolation and characterization of monoclonal antibodies (mAb) have yielded a plethora of mAbs which target conserved regions of influenza virus, such as the hemagglutinin (HA) stem region. Many such mAbs have been used to gain a better understanding of Fc-receptor functions in vivo. In parallel, several studies have characterized the induction of polyclonal ADCC following influenza vaccination and infection in humans. Taken together, these studies suggest that ADCC-mediating antibodies (ADCC-Abs) significantly contribute to host immunity against influenza virus and may be a mechanism to exploit for rational vaccine and therapeutic design. We discuss recent research on influenza-specific ADCC and potential future avenues to extend our understanding.Keywords
This publication has 94 references indexed in Scilit:
- Comparative Efficiency of HIV-1-Infected T Cell Killing by NK Cells, Monocytes and NeutrophilsPLOS ONE, 2013
- Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1The Journal of Infectious Diseases, 2013
- Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of MacaquesJournal of Virology, 2013
- Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG BindingJournal of Virology, 2012
- An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 SerumJournal of Virology, 2011
- Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza VirusPublished by The American Association of Immunologists ,2011
- A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus InfectionPLOS ONE, 2011
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective ImmunityPLOS ONE, 2011
- Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virusProceedings of the National Academy of Sciences of the United States of America, 2010
- Human neutrophils lack granzyme A, granzyme B, and perforinBlood, 2004